Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review

doi:10.4251/wjgo.v16.i8.3397

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1192)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

HTML

717

Figures (1-6)

109

Tables (1-1)

101

Sum=957

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

142

Sum=195

Aug 15, 2024 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3397-3409
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3397

Table 1 List of c-Met inhibitors

Drug (alternative name)	Study	Phase
Crizotinib (PF0234I066)	NCT00585I95	I
Cabozantinib (XL184)	NCT0I8664I0	II
	NCT0I708954	II
	NCT00940225	II
Foretinib (GSKI363089)	NCT0I068587	I/II
Tepotinib (EMDI2I4063)	NCT02864992	II
Rilotumumab (AMG102)	NCT02137343	III
Ficlatuzumab	NCT03422536	II
Tivantinib (ARQ197)	NCT01244191	III
Capmatinib (INC280, INCB28060)	NCT0I324479	I
	NCT0I60336	II

Citation: Wei WJ, Hong YL, Deng Y, Wang GL, Qiu JT, Pan F. Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review. World J Gastrointest Oncol 2024; 16(8): 3397-3409
URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3397.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3397